share_log

HC Wainwright & Co. Reiterates Buy on Actinium Pharma, Maintains $50 Price Target

HC Wainwright & Co. Reiterates Buy on Actinium Pharma, Maintains $50 Price Target

HC Wainwright & Co.重申買入Actinium Pharma,維持50美元的目標股價
Benzinga ·  05/21 06:52

HC Wainwright & Co. analyst Joseph Pantginis reiterates Actinium Pharma (AMEX:ATNM) with a Buy and maintains $50 price target.

HC Wainwright & Co. 分析師約瑟夫·潘吉尼斯重申Actinium Pharma(AMEX: ATNM)的買入並維持50美元的目標股價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論